Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
- To elucidate the immunomodulating properties of anti-TNF-α therapy in patients with
psoriatic arthritis (PsA).
- To ascertain whether magnetic resonance imaging (MRI) is a sensitive tool in measuring
early response after therapy with anti-TNF-α in the PsA wrist using the Outcome Measures
in Rheumatoid Arthritis Clinical Trials (OMERACT) guidelines for rheumatoid arthritis
(RA).
- To assess whether the lipid and other cardiovascular risk profiles would improve after
anti-TNF-α therapy in patients with PsA.